Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck

Japanese Journal of Clinical Oncology

Volumn 29, Issue 10, 1999, Pages 462-466

  Kohno, Naoyuki ^a   Kitahara, Satoshi ^a   Kawaida, Masahiro ^b   Ohmuma, Takao ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Head and neck; Prognosis; Salvage chemotherapy; Unresectable recurrent cancer

Indexed keywords

1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; CF REGIMEN; CISPLATIN; FLUOROURACIL; TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SALVAGE THERAPY; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 0033202261     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.10.462     Document Type: Article

References (20)

1. Wolf GT, Lippman SM, Laramore GE, Hong WK, Head and neck cancer. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR, editors. Cancer Medicine, 3rd ed. Philadelphia: Lea & Febiger 1993;1211-75.
2. Ervin TJ, Weichselbaum RR, Miller D, Meshad M, Posner M, Fabian R. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin and methotrexate (PBM). Cancer Treat Rep 1981;65:787-91.
3. Dreyfuss AI, Clark JR, Wright JE, Noms CM Jr, Busse PM, Lucarini JW, et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990;112:167-72.
4. Thyss A, Schneider M, Santini J, Caldani C, Vallicioni J, Cauvel P, et al. Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer 1986;54:755-60.
5. Vokes, EE, Schilsky RL, Weichselbaum RR, Kozloff MF, Panje WR. Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 1990;8:241-7.
6. Rowland KM, Taylor SG, O'Donnell MR, Showel J, Scott PB, Milner LM, et al.Cisplatin and 5-FU infusion chemotherapy in advanced recurrent cancer of the head and neck. Cancer Treat Rep 1986;70:461-4.
7. Creagan ET, Ingle JN, Schutt AJ, O'Fallon JR. A phase II study of cisdiaminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms. Head Neck Surg 1984;6:1020-3.
8. Choksi AJ, Hong WK, Dimery IW, James P, Guillamondegui OM, Byers RM. Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell cancer. Cancer 1988;61:909-12.
9. Kohno N, Ichikawa G, Shirasaka T, Inuyama Y, Kawaida M, Ohnuma T. Salvage chemotherapy with Pem and long-CF regimen in CDDP refractory advanced head and neck cancer. Jpn J Cancer Chemother 1995;22(Suppl III):209-14.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1953;53:457-81.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
12. Drelichman A, Cummings G, Al-Sarraf M. A randomized trial of the combination of cisplatinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck. Cancer 1983;52:399-403.
13. Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian RL, et al.An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1987;5:10-20.
14. Schabel FN, Trader MW, Lasler WR, Corbett TH, Griswold DP Jr. Cis-dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treatment Rep 1979;63:1459-73.
15. Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors. Presidential Address. Cancer Res 1988;48:775-8.
16. Kohno N, Ohnuma T, Kaneko M, Holland J. Interactions of doxorubicin and cisplatin in squamous carcimona in culture. Br J Cancer 1988;58:330-4.
17. Kohno N, Ichikawa G, Inuyama Y, Ohnuma T. Induction chemotherapy with PEM regimen in advanced head and neck cancer. Proc Am Assoc Cancer Res 1992;33:224.
18. Levin L, Hryniuk WM. Dose intensity analysis of chemotherapy regimen in ovarian carcinoma. J Clin Oncol 1987;5:756-67.
19. Kohno N, Ohnuma T, Billar HF, Holland J. Effects of cisplatin plus fluorouracil vs cisplatin plus cytarabine on head and neck squamous multicellular tumor spheroids. Arch Otolaryngol Head Neck Surg 1988;114:157-61.
20. 1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 1998;4:2085-8.